A Single-arm, Open-label, Prospective Clinical Study of Surufatinib Combined With Immunotherapy and Chemotherapy for Unresectable or Metastatic Biliary Tract Cancer.
PHASE2
This is a single-arm, open-label, prospective clinical study aimed at obser...
The Efficacy and Safety of LM-302 in Combination With Candonilimab and Capecitabine for First-Line Treatment in Patients With Unresectable Advanced, Recurrent, or Metastatic CLDN18.2-Positive Gastric or Gastroesophageal Junction Adenocarcinoma
PHASE2
A Phase II Study Evaluating the Efficacy and Safety of LM-302 in Combinatio...
A Pilot Study Evaluating ฮฒ-hydroxybutyrate Supplementation Concomitant to Short-Course Radiotherapy Followed by Immunotherapy Combined With CAPEOX Neoadjuvant Therapy in Patients With Locally Advanced Rectal Cancer
PHASE2
This study is a prospective phase II clinical trial aimed at exploring the ...
Status
Recruiting
Location
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
A Study of the Zanubrutinib Given in Combination With Bendamustine and Rituximab in (Elderly or TP53 Alterations or Chemotherapy Intolerance) Patients With Newly Diagnosed Mantle Cell Lymphoma
PHASE2
The purpose of this study is to evaluate the efficacy and safety of Zanubru...